These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2884853

  • 1. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
    Pool JL.
    Am J Cardiol; 1987 May 29; 59(14):46G-50G. PubMed ID: 2884853
    [Abstract] [Full Text] [Related]

  • 2. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    Pool JL, Taylor AA, Nelson EB.
    Am J Med; 1989 Aug 16; 87(2A):57S-61S. PubMed ID: 2569825
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT, Schonfeld G, Reeves RL, Black H, Weidler DJ.
    Am J Cardiol; 1987 May 29; 59(14):87G-90G. PubMed ID: 2884859
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacotherapeutics of doxazosin.
    Taylor SH.
    Am J Med; 1989 Aug 16; 87(2A):2S-11S. PubMed ID: 2569822
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Aug 16; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R, Angeli-Greaves M, Carvajal AR, Guerrero Pajuelo J, Armas Padilla MC, Armas-Hernández MJ.
    Am J Hypertens; 1996 May 16; 9(5):437-44. PubMed ID: 8735174
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May 16; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.